Abstract:Background: Ischemia-reperfusion (I/R) injury, which leads to additionally cardiac tissue damage, is a severe adverse effect of reperfusion therapeutics used for the treatment of acute myocardial infarction. Agents capable of alleviating I/R-induced myocardial injury are urgently needed. In this study, we investigated whether up-regulation of PERK/Nrf2/HO-1 axis provided protective roles for murine myocardium suffering I/R intervention. Methods: The in vivo I/R model was formed by ligation of the left anterior descending (LAD) coronary artery of C57BL/6J mice. All animals were assigned into the following groups at random: sham, I/R, rAAV9-PERK + I/R, rAAV9-Nrf2 + I/R, rAAV9-HO-1 + I/R, siRNA-HO-1 + rAAV9-PERK + I/R. The ligation of LAD was released after 30 min of ischemia, which was followed by reperfusion of LAD for 4 h. Then the cardiac tissues and blood serum were collected. TUNEL staining, ELISA assay, TTC staining, Western blotting and real-time PCR were used to determine I/R injury-related indicators. Results: Our results showed that I/R administration triggered cardiomyocytes apoptosis and LDH and CK-MB release, yet overexpression of PERK decreased cellular apoptosis index in the cardiac tissue and reduced levels of LDH and CK-MB in the serum. We further found that the protective actions of PERK against I/R-evoked cardiac damage might be attributed to up-regulation of Nrf2/HO-1 signaling transduction, given that overexpression of Nrf2 and HO-1 ameliorated cardiac cell apoptosis and reduced the size of infarction and ischemia in the myocardial tissue, yet gene silencing of HO-1 invalidated the beneficial roles of PERK overexpression in improving I/R-induced cardiac injury. Then, we investigated whether PERK-activated Nrf2/HO-1 cascade affected endoplasmic reticulum stress (ERS), considering the crucial roles of ERS-associated apoptosis in the development of I/R damage. Our findings indicated that up-regulation of PERK-mediated Nrf2/HO-1 pathway induced the expression reduction of GRP78, CRT, CHOP and caspase-12 both at the transcriptional and translational level. Conclusions: We, for the first time, discovered that up-regulation of PERK/Nrf2/HO-1 axis improved I/R-induced myocardial injury via reducing ERS-related signal molecules and downstream pro-apoptotic factors.

HSPA12B Attenuated Acute Myocardial Ischemia/reperfusion Injury via Maintaining Endothelial Integrity in a PI3K/Akt/mTOR-dependent Mechanism

Over-expression of HSPA12B Protects Mice Against Myocardium Ischemic/reperfusion Injury Through a PPARγ-dependent PI3K/Akt/eNOS Pathway.

Cardioprotection by Polysaccharide Sulfate Against Ischemia/reperfusion Injury in Isolated Rat Hearts.

Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism.

RETRACTED: Over-expression of HSPA12B protects mice against myocardium ischemic/reperfusion injury through a PPAR gamma-dependent PI3K/Akt/eNOS pathway (Retracted article. See vol. 8, pg. 1625, 2016)

HSPA12A maintains aerobic glycolytic homeostasis and Histone3 lactylation in cardiomyocytes to attenuate myocardial ischemia/reperfusion injury

HSPA12A Stimulates P38/erk-Ap-1 Signaling to Promote Angiogenesis and is Required for Functional Recovery Postmyocardial Infarction.

HSPA12A Improves Endothelial Integrity to Attenuate Lung Injury During Endotoxemia Through Activating ERKs and Akt-dependent Signaling.

Abstract 19689: Kdm3a Protects Myocardium from Ischemia/reperfusion Injury Through Targeting Akt-dependent Signaling Pathways

HSPA12A stimulates "Smurf1-Hif1α-aerobic glycolysis" axis to promote proliferation of renal tubular epithelial cells after hypoxia/reoxygenation injury

RP105-PI3K–Akt Axis: A Potential Therapeutic Approach for Ameliorating Myocardial Ischemia/reperfusion Injury

HSPA12B Promotes Functional Recovery after Ischaemic Stroke Through an Enos-Dependent Mechanism.

HSPA12A promotes c-Myc lactylation-mediated proliferation of tubular epithelial cells to facilitate renal functional recovery from kidney ischemia/reperfusion injury

Investigation of Helix B-surface Peptide Protecting the Cardiac Micro-vascular Endothelial Cell Injury by Ischemia/reperfusion in Experimental Rats

Upregulation of Hsp27 via further inhibition of histone H2A ubiquitination confers protection against myocardial ischemia/reperfusion injury by promoting glycolysis and enhancing mitochondrial function

Helix B surface peptide is cardioprotective through inhibition on myocardial apoptosis induced by ischemia/reperfusion injury

Isthmin-1 alleviates cardiac ischemia/reperfusion injury through cGMP-PKG signaling pathway

Ppolyhb Protects Myocardial H9C2 Cells Against Ischemia-Reperfusion Injury by Regulating the Pink1-Parkin-mediated Mitochondrial Autophagy Pathway.

Inhibiting H2AX Can Ameliorate Myocardial Ischemia/Reperfusion Injury by Regulating P53/JNK Signaling Pathway

Endothelial-Targeted Overexpression Of Heat Shock Protein 27 Ameliorates Rapid Blood Brain Barrier Impairment And Improves Long Term Outcomes After Ischemia And Reperfusion

Up-regulation of PERK/Nrf2/HO-1 axis protects myocardial tissues of mice from damage triggered by ischemia-reperfusion through ameliorating endoplasmic reticulum stress